A Single Center Experience Using Alemtuzumab, Fludarabine, Melphalan and Thiotepa as Conditioning for Transplant in Chronic Granulomatous Disease
2017
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI